Pharmaceutical Technology Europe-02-11-2011

Pharmaceutical Technology Europe

February 11, 2011

I can't remember a day go by in the last few years when I haven't received an email or item of mail inviting me to attend a conference or trade event

Pharmaceutical Technology Europe

Kris Schoeters of GEA Pharma Systems explains how pharma's uptake of continuous processing is changing.

Industry Insider
Pharmaceutical Technology Europe

February 11, 2011

The recent India–EU summit was expected to bring news about the upcoming Free Trade Agreement between the EU and India; however, a dispute regarding the supply of generic drugs from India to developing countries has taken centre stage.

Pharmaceutical Technology Europe

The pharma industry is constantly seeking drug delivery technologies that can increase compliance, improve the quality of delivered care, reduce medication errors and reduce the possibility of admixture-related contamination.

Special Feature
Pharmaceutical Technology Europe

February 11, 2011

Needle-free injection technologies have been developed for injecting liquid formulations, as well as injecting drugs and vaccines in a solid dosage form.

Manufacturing
Pharmaceutical Technology Europe

February 11, 2011

With the increasing importance of novel dosage forms, the use of release liners as components of transdermal delivery systems, oral thin films and buccal mucosal systems is on the rise.

Pharmaceutical Technology Europe
News

February 11, 2011

GSK to pay more than $4 billion for criminal and legal charges; FDA gains food recall authority... are drugs next?

Pharmaceutical Technology Europe
Disposables Advisor

February 11, 2011

Over the past 10 years or so, we've seen single-use technologies explode from production-scale filter capsules, tubing and simple biocontainers to encompass sterile connectors, membrane chromatography adsorbers, bioreactors, mixers, and integrated platform systems with increasing levels of sensors and automated controls.

Pharmaceutical Technology Europe

The application of the first piston syringes to treat medical complications was described in Roman times during the 1st century, and forms of intravenous injection and infusion began as early as 1670.

Drug Delivery
Pharmaceutical Technology Europe

February 11, 2011

The way in which a suspension nasal spray product interacts with the body depends not only on the droplet size of the delivered droplet, but also on the particle size of the suspended API.

Special Feature
Pharmaceutical Technology Europe

February 01, 2011

An interview with Vetter's Oskar Gold about the trends and growth in prefilled syringes.